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Abstract
Examining fatal poisonings, chronic exposure may be reflected by the concentration in tissues known for long-term storage 
of drugs. Δ9-tetrahydrocannabinol (THC) persists in adipose tissue (AT), but sparse data on synthetic cannabinoids (SC) are 
available. Thus, a controlled pig study evaluating antemortem (AM) disposition and postmortem (PM) concentration changes 
of the SC 4-ethylnaphthalene-1-yl-(1-pentylindole-3-yl)methanone (JWH-210) and 2-(4-methoxyphenyl)-1-(1-pentyl-indole-
3-yl)methanone (RCS-4) as well as THC in AT was performed. The drugs were administered pulmonarily (200 µg/kg body 
weight) to twelve pigs. Subcutaneous (s.c.) AT specimens were collected after 15 and 30 min and then hourly up to 8 h. 
At the end, pigs were sacrificed and s.c., perirenal, and dorsal AT specimens were collected. The carcasses were stored at 
room temperature (RT; n = 6) or 4 °C (n = 6) and specimens were collected after 24, 48, and 72 h. After homogenization in 
acetonitrile and standard addition, LC–MS/MS was performed. Maximum concentrations were reached 0.5–2 h after admin-
istration amounting to 21 ± 13 ng/g (JWH-210), 24 ± 13 ng/g (RCS-4), and 22 ± 20 ng/g (THC) and stayed at a plateau level. 
Regarding the metabolites, very low concentrations of N-hydroxypentyl-RCS-4 (HO-RCS-4) were detected from 0.5 to 8 h. 
PM concentrations of parent compounds did not change significantly (p > 0.05) over time under both storage conditions. 
Concentrations of HO-RCS-4 significantly (p < 0.05) increased in perirenal AT during storage at RT. These results suggest a 
rapid distribution and persistence in s.c. AT. Furthermore, AT might be resistant to PM redistribution of parent compounds. 
However, significant PM increases of metabolite concentrations might be considered in perirenal AT.
Keywords Synthetic cannabinoids · Tetrahydrocannabinol · Adipose tissue, postmortem redistribution · Pigs · Pulmonary 
administration
Introduction
Interpreting postmortem (PM) drug concentrations in the 
context of death investigation, consumption habits, that is 
to say acute versus chronic consumption, have to be con-
sidered. Assessing analytical findings in tissues known for 
long-term persistence of substances concerning that issue 
might be helpful. Although a precise determination of the 
time of consumption is not possible, adipose tissue (AT) 
proved to be an alternative specimen for detecting drugs, 
pharmaceuticals, and pollutants, especially lipophilic ones, 
in PM toxicology (Colucci et al. 2010; De Saeger et al. 2005; 
Hikiji et al. 2010; Mühlebach et al. 1985; Shintani-Ishida 
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et al. 2018). Contrary to blood, AT is available in higher 
amounts, even if a decedent is already putrefied.
Furthermore, a study by Levisky et al. (2001) provided 
data on drugs detected in PM AT specimens. Those results 
implicated that determination of drugs in this tissue prove 
an antemortem (AM) disposition not being affected by PM 
redistribution (PMR). However, this study was based on data 
from authentic autopsy cases and was burdened with the 
uncertainty that time of intake, dose and PM interval (PMI) 
were unknown.
∆9-Tetrahydrocannabinol (THC), a highly lipophilic drug, 
has already extensively been studied in terms of its toxicoki-
netic (TK) properties. It is well-known that THC is stored in 
AT. Kreuz and Axelrod (1973) demonstrated a persistence 
for 2 weeks after single dose administration and Johansson 
et al. (1989) detected THC in human AT specimens from 
heavy marihuana users 4 weeks after having smoked their 
last four cigarettes before sampling. Rawitch et al. (1979) 
examined the time-dependent uptake of THC into mouse 
AT of different regions following a single intraperitoneal 
injection. The authors found a preferential accumulation in 
gonadal fat. Brunet et al. (2010) investigated the PMR of 
THC in pigs following a single intravenous administration, 
but they did not determine the AM uptake of THC into AT.
The highly lipophilic synthetic cannabinoids (SC) should 
show a comparable distribution and persistence in the body, 
but so far very little is known about their TK and toxicody-
namics (TD). A number of case reports have already been 
published discussing a contribution of SC to the fatal out-
come and describing the (adipose) tissue distribution (Krae-
mer et al. 2019). However, those data should be interpreted 
with caution, because in most of the cases, dose and time of 
drug intake as well as time of death and PMI were unknown. 
Controlled systematic human studies are not allowed for 
ethical reasons, but TK studies are necessary for a better 
understanding of the toxicology of those substances. Thus, 
animal studies have to be performed.
Poklis et al. (2012b) studied the disposition of JWH-
018 and JWH-073 in mouse blood and brain after exposure 
to “Magic Gold” smoke and also determined JWH-018 in 
different organs of the mouse after inhalation exposure to 
“buzz” smoke (Poklis et al. 2012a; Wiebelhaus et al. 2012). 
However, they did not assess SC concentrations in AT. In 
fact, data of only two studies on the distribution of SC AT 
in rodents are available. In the first study including three 
mice, 30% of the total intraperitoneally injected dose of the 
SC WIN55,212-2 were detected after 30 min in AT (Barna 
et al. 2009). In the second study we showed a storage of the 
SC JWH-122 and JWH-210 for at least four weeks follow-
ing single oral administration to rats (Schaefer et al. 2014). 
However, these studies only included a small number of 
animals. In addition, no time-course of AM uptake into AT 
was investigated.
Recently, we established a pig model allowing for eluci-
dation of cannabinoid TK after pulmonary administration 
of 4-ethylnaphthalene-1-yl-(1-pentylindole-3-yl)methanone 
(JWH-210), 2-(4-methoxyphenyl)-1-(1-pentyl-indole-3-yl)
methanone (RCS-4), and THC (Schaefer et al. 2018a, b). 
The chemical structures are depicted in Fig. 1. As part of the 
study, AM data on the distribution of the cannabinoids and 
their main metabolites (see Fig. 1) in blood (Schaefer et al. 
2018a, b), perimortem data on the distribution in different 
organs at the time of death (Schaefer et al. 2019) as well 
as time- and temperature-dependent concentration changes 
were provided. Pigs were chosen, because they have already 
been proven to be suitable for the examination of PM con-
centrations of central nervous acting substances (Brunet 
et al. 2010; Crandall et al. 2006; Flanagan et al. 2003; Hil-
berg et al. 1998).
In the present study, the AM uptake into subcutaneous 
(s.c.) AT should be examined. In addition, it should be 
Fig. 1  Molecular structures of the tested drugs and their main metabolites
3423Archives of Toxicology (2020) 94:3421–3431 
1 3
investigated, whether the concentrations of the drugs stay 
stable in AT, and thus, if AT is suitable for PM detection 
of cannabinoids. For this purpose, the perimortem and PM 
distribution in AT of different anatomical regions and the 
time- and temperature-dependent concentration changes 




Formic acid and HPLC grade water were purchased from 
VWR-International (Darmstadt, Germany), and ethanol p.a. 
and HPLC grade acetonitrile from Sigma-Aldrich (Stein-
heim, Germany). Methanolic solutions of THC (0.1 mg/
mL), THC pharmaceutical grade for drug administration 
(Dronabinol, DAC 2008, 98.5% purity), JWH-210 (solid), 
and RCS-4 (solid) were purchased from THC Pharm (Frank-
furt/Main, Germany), THC-d3 (98.9% purity, 0.07% THC-
d0), 11-hydroxy-THC (HO-THC), HO-THC-d3 (99.6% 
purity, 0.17% HO-THC-d0), 11-nor-9-carboxy-THC (THC-
COOH), and THC-COOH-d3 solution (99.5% purity, 0.02% 
THC-COOH-d0, 0.1 mg/mL each) were obtained from LGC/
Promochem (Wesel, Germany), and methanolic solutions of 
JWH-210-d9 (1 mg/mL, ≥ 99% purity) and RCS-4-d9 (5 mg/
mL, ≥ 99% purity), hydroxypentyl-RCS-4 (HO-RCS-4) solu-
tion (10 mg/mL in acetonitrile), hydroxypentyl-JWH-210 
(HO-JWH-210, solid), JWH-210-pentanoic acid (JWH-210-
COOH, solid), and RCS-4-pentanoic acid (RCS-4-COOH, 
solid) from Cayman Europe (Tallinn, Estonia). The German 
Federal Criminal Police Office (Wiesbaden, Germany) pro-
vided JWH-210 used for drug administration with a purity 
of 98.3%. RCS-4 (96% purity) was purchased as ‘research 
chemical’ from an internet provider.
Calibrators for standard addition
As already described in previous studies (Schaefer et al. 
2019, 2020), the preparation of standard stock solutions 
(1 mg/mL) was performed by dissolving 5 mg of each solid 
compound in 5 mL of ethanol. Concentrations of working 
standard solutions (0.001 mg/mL, 0.01 mg/mL, 0.1 mg/mL) 
were obtained by diluting the stock solutions or liquid refer-
ence standards with ethanol, respectively. The concentra-
tions of the calibrators used for standard addition were 20, 
40, and 60 ng/g. All solutions were stored at − 20 °C.
Animals
As described previously (Schaefer et al. 2019, 2020), twelve 
domestic male pigs (Swabian Hall strain; body weight (BW) 
40.5–49.8 kg) were used for the study. They had free access 
to tap water and daily standard chow. They were kept fasting 
a night before the experiment and had free access to water.
Surgical procedures
Surgical procedures have previously been described 
(Schaefer et al. 2015, 2016, 2017a, b, 2018a, b, 2019, 2020). 
At first, the animals received an intramuscular injection of 
xylazine hydrochloride (2.5 mg/kg, Rompun; Bayer, Lev-
erkusen, Germany), ketamine hydrochloride (30 mg/kg, 
Ursotamin; Serumwerk Bernburg, Bernburg, Germany), 
and atropine (1 mg, Braun, Melsungen, Germany). Anal-
gosedation was performed with isoflurane (2–4%, Forene, 
AbbVie, Ludwigshafen, Germany), mechanical ventilation 
with a mixture of oxygen and air (1:2 vol/vol;  FiO2 of 0.30; 
Respirator ABV-U; F. Stephan GmbH, Gackenbach, Ger-
many) and volume cycling with a tidal volume of 10–12 mL/
kg. A triple-lumen 7F (Certofix Trio, Braun, Melsungen, 
Germany) central venous catheter was inserted into the jugu-
lar vein for monitoring of mean central venous pressure. One 
catheter was set into the left ear vein to replace fluid (sodium 
chloride 0.9% [8 mL kg−1 h−1], Braun, Melsungen, Ger-
many). To measure invasive blood pressure and blood gases, 
the left femoral artery was catheterized (Leadercath Expert 
14G, Vygon, Aachen, Germany). Finally, a suprapubic cath-
eter (Cystofix, Braun, Melsungen, Germany) was placed into 
the bladder for urine sample collection. The animals were 
then allowed to stabilize for 10–15 min.
Study design
As already described elsewhere (Schaefer et al. 2018a, b, 
Schaefer et al. 2019, 2020), at first, a stock solution (7.5 mg/
mL of JWH-210, RCS-4, and THC each) was prepared in 
ethanol. To obtain a 200 µg per kg BW dose, the appropri-
ate volume of the solution (1080–1328 µL) was applied, 
respectively. The drugs were administered to 12 pigs within 
12 min by nebulization using the inspiration-triggered mode 
(< 0.2 mL/min) of the M-neb  flow+ ventilation ultrasonic 
nebulizer MN-300/7 (Nebutec, Elsenfeld, Germany) allow-
ing for simulation of authentic user habits (Schaefer et al. 
2018a, b).
Subcutaneous AT specimens were collected ventrally 
15 and 30 min after administration and then hourly up to 
8 h. As described previously (Schaefer et al. 2019), 8 h 
after administration (PMI 0), the animals were euthanized 
with T 61 (0.12 mL/kg BW, Intervet Deutschland GmbH, 
Unterschleißheim, Germany) and the abdominal cavity was 
opened. Specimens of perirenal AT were collected and the 
abdominal cavity was sutured. Additionally, dorsal AT was 
sampled from the back of the animals.
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The animals were stored at room temperature (RT; n = 6) 
or 4 °C (n = 6) in a supine position and further specimens 
were collected after 24, 48, and 72 h (PMI 1–3) each as 
described above. All samples were stored at − 20 °C until 
analysis.
Sample preparation
AT specimens were prepared according to Schaefer et al. 
(2014) applying slight modifications. An amount of 2 g AT 
was homogenized (1 amount tissue + 5 amounts acetoni-
trile). Subsequently, four 0.5-g portions were prepared with 
and without addition of 20 ng/g, 40 ng/g, or 60 ng/g of JWH-
210, HO-JWH-210, JWH-210-COOH, RCS-4, HO-RCS-4, 
RCS-4-COOH, THC, 11-HO-THC, and THC-COOH to cre-
ate a standard addition calibration curve. After centrifuga-
tion at 3500×g for 8 min, 1.5 mL of the supernatants were 
added to 20 µL of an ethanolic stable-isotope-labeled inter-
nal standard mixture solution (2 ng/20 µL of JWH-210-d9 
and RCS-4-d9, 10 ng/20 µL of THC-d3) and evaporated 
under nitrogen at 60 °C. The dry residues were dissolved 
in 100 µL of mobile phase A/B (50:50, v/v). Mobile phase 
A was 0.1% aqueous formic acid and B consisted of 0.1% 
formic acid in acetonitrile. Twenty microliters were then 
injected onto the liquid chromatography tandem-mass spec-
trometry (LC–MS/MS) system.
Standard addition method
For quantification of the drugs and their metabolites in AT 
specimens, the standard addition approach was chosen. Four 
portions were prepared of each specimen, one containing no 
calibrator solution and three containing different concentra-
tions of calibrator solution. Subsequently, regression analy-
sis was performed. Standard addition calibration equations 
were created as follows: y = a x + b. Depending on the slope 
(a) and the intercept (b) the calibration curve intersects the 
x-axis at the negative side. The point of intersection repre-
sents the unknown concentration.
Apparatus
LC–MS/MS
LC–MS/MS conditions including instrumentation, chroma-
tographic, and mass spectrometric conditions for the analysis 
of extracts have already been described elsewhere (Schaefer 
et al. 2015, 2017b, 2019, 2020). In brief, a Thermo Fisher 
(TF, Dreieich, Germany) HPLC was applied consisting of 
one Allegro pump and an HTC PAL autosampler. Applying 
a TF TSQ Quantum Ultra Accurate Mass triple stage mass 
spectrometer with an atmospheric pressure chemical ioniza-
tion (APCI) interface running in the positive mode detection 
was achieved. The column was a Waters (Wexford, Ireland) 
Sunfire  C18 column (150 × 2.1 mm, 3.5 µm). Gradient elution 
was carried out using mobile phase A and B. The runtime 
was about 10 min. Ionization was performed with the APCI 
source in positive mode and following settings: discharge 
current 5.0 µA; vaporizer temperature 400 °C; sheath gas 
40 arbitrary units; auxiliary gas 15 arbitrary units; capil-
lary temperature 270 °C. Detection and quantification of the 
compounds were performed in multiple-reaction monitor-
ing mode with three transitions per precursor ion (Schaefer 
et al. 2018a, b). TF Xcalibur Version 2.0.7 SP 1 software 
was used.
Calculation of concentrations changes
In accordance to a recent study (Schaefer et al. 2020), the 
median concentration changes of the drugs (and their metab-
olites) determined in s.c., perirenal and dorsal AT specimens 
at PMI 1-3 in comparison with the median concentrations 
assessed right after death = PMI 0 were calculated using the 
following equation:
A value higher than zero would indicate a concentration 
increase, a value lower than zero a concentration decrease.
Statistical tests
For examination of the mean time-dependent concentration 
changes in the different AT specimens a non-parametric 
Friedman-test (p < 0.05) followed by the Dunn’s multiple 
comparison posthoc test was applied. A non-parametric 
Mann–Whitney U-test (p < 0.05) was carried out to compare 
concentrations determined after storage at RT with those 
determined after storage at 4 °C. Statistics were performed 




The drugs and their metabolites were quantified in AT spec-
imens applying the standard addition method. Regression 
coefficients (r2) for JWH-210, RCS-4 and THC as well as 
HO-RCS-4 ranged between 0.95 and 0.99.
AM disposition
JWH-210, RCS-4 and THC could be detected in every AM 
AT specimen of the 12 pigs. Mean maximum concentrations 
Δc (%) = (c(PMI 1 − 3)−c(PMI 0))∕c(PMI 0) × 100
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were reached in AM s.c. AT samples 0.5–2 h after admin-
istration and amounted to 21 ± 13  ng/g (JWH-210), 
24 ± 13 ng/g (RCS-4), and 22 ± 20 ng/g (THC; see Table 1). 
In the following, concentrations stayed at the same level. 
After 8 h, concentrations were still at the plateau level 
(Table 1).
Regarding the metabolites, only very low concentra-
tions of HO-RCS-4 with comparably high variabilities 
were detected in 8 pigs from 0.5 to 8 h (Table 1). No fur-
ther metabolites were found in the analyzed AM s.c. AT 
specimens.
PM concentrations and time‑ 
and temperature‑dependent concentration changes
In general, high interindividual differences were observed 
in the analyzed PM specimens at PMI 0–3 under two dif-
ferent storage conditions. The median and mean concentra-
tions (and their standard deviations; SD) of the parent com-
pounds and the metabolite HO-RCS-4 are listed in Table 2. 
JWH-210, RCS-4 and THC could be detected in every PM 
AT specimen. At the time of death, mean concentrations of 
JWH-210 were highest in perirenal AT and lowest in dorsal 
AT (Table 2). Mean concentrations of RCS-4 were similar in 
s.c., perirenal and dorsal AT (Table 2). As for THC, lowest 
mean concentrations were determined in dorsal AT, whereby 
similar concentrations were found in s.c. and perirenal AT 
(Table 2).
PM mean concentrations of parent compounds in s.c., per-
irenal, and dorsal AT did not change significantly (p > 0.05) 
over time under both storage conditions (Table 2). Median 
concentration changes are depicted in Fig. 2a–c. Regarding 
JWH-210, only minor differences were observed of concen-
trations at PMI 1–3 as compared to PMI 0 throughout the 
tested specimens. Concentrations increased only slightly in 
dorsal AT stored at RT (Fig. 2a, Table 2). Concerning RCS-
4, slight continuous concentration increases were assessed 
in perirenal AT during the whole observation period (stor-
age at RT and 4 °C each, see Fig. 2b, Table 2). However, the 
concentrations in dorsal AT decreased during storage at 4 °C 
(Fig. 2b, Table 2). With regard to THC, a slight increase of 
concentrations determined in dorsal AT of pigs stored at RT 
was observed (Fig. 2c, Table 2).
As for the detectability of metabolites in PM AT speci-
mens, only HO-RCS-4 could be found. This metabolite was 
detected in s.c. AT specimens of every pig stored at RT and 
of 3 out of 6 pigs stored at 4 °C, respectively (see Table 2). 
In perirenal AT specimens, HO-RCS-4 was detected in 5 
of 6 pigs stored at RT and 4 °C, respectively. In dorsal AT 
specimens, the metabolite was identified in 4 of 6 animals 
stored at 4 °C and in 3 of 6 animals stored at RT, respec-
tively (see Table 2). No significant changes of mean PM 
concentrations could be observed except for concentrations 
determined in perirenal AT showing a significant (p < 0.05) 
time-dependent increase of HO-RCS-4 in specimens stored 




The total doses of JWH-210, RCS-4, and THC administered 
inhalatively amounted to 8.1–9.9 mg. These dosages were 
comparable with SC doses used in controlled animal stud-
ies or human self-experiments (Castaneto et al. 2015) as 
well as THC doses applied in human studies with inhalative 
consumption (Desrosiers et al. 2014; Hazekamp et al. 2006).
Standard addition method
As already discussed elsewhere (Schaefer et al. 2020), the 
standard addition approach is more labor-intensive as com-
pared to the conventional method validation, but matrix 
effects are leveled (Jickells and Negrusz 2008) because of 
matrix-matched calibration curves. Especially in PM toxi-
cology this issue is of importance, as matrix effects can be 
challenging due to purification of specimens. In addition, 
in common validation procedures the use of blank matrix 
from different individuals is demanded for the assessment of 
several parameters. However, in case of PM specimens this 
might lead to unrepresentative results, since interindividual 
biological variances of the same matrix specimens have to 
be considered. For this purpose, national and international 
Table 1  Mean concentrations [± standard deviation (SD)] of JWH-
210, RCS-4, HO-RCS-4 and THC in antemortem (AM) subcuta-
neous (s.c.) adipose tissue (AT) following a single pulmonary dose 
of 200  µg/kg body weight each to pigs (n = 12); concentrations are 
approximated and the mean of 12 values except for HO-RCS-4 (8 
replicates); n.d. not detected
T (h) Mean AM s.c. AT concentration
± SD (ng/g)
JWH-210 RCS-4 HO-RCS-4 THC
0.25 10 ± 8 13 ± 7 n.d. 14 ± 6
0.5 11 ± 6 19 ± 11 1 ± 1 22 ± 20
1 21 ± 13 22 ± 17 3 ± 2 18 ± 14
2 15 ± 10 24 ± 13 2 ± 1 22 ± 20
3 18 ± 9 23 ± 12 3 ± 2 17 ± 9
4 23 ± 17 21 ± 13 3 ± 2 20 ± 14
5 22 ± 20 19 ± 9 3 ± 2 20 ± 8
6 18 ± 12 19 ± 13 2 ± 1 18 ± 11
7 22 ± 24 17 ± 13 2 ± 2 20 ± 18
8 16 ± 5 20 ± 9 1 ± 1 20 ± 13
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guidelines recommend the application of the standard addi-
tion method for quantification of drugs in (PM) tissue speci-
mens (GTFCh 2018; Jickells and Negrusz 2008; Peters et al. 
2007; Skopp 2010; SOFT/AAFS 2006).
Taking into account the high purity of the stable-isotope-
labeled internal standards guaranteed by the vendor, no 
relevant interferences with the analytical results had to be 
expected. As described previously (Schaefer et al. 2020), the 
concentrations of the calibrators were determined accord-
ing to a rough semiquantitative estimation of the amount 
found in initial analyses. The calibrator concentrations were 
accordingly adjusted. The calibration curves were regarded 
to be linear with r2 > 0.95.
AM distribution
The results suggest a rapid uptake of the parent compounds 
into s.c. AT with THC most rapidly reaching the maximum 
concentrations (Table 1). The fact that RCS-4 concentra-
tions in s.c. AT specimens peaked latest after 2 h might be 
explained by a lower lipophilicity (Table 3) and a much 
faster metabolization rate as compared to the other two can-
nabinoids (Schaefer et al. 2018a, b).
The data of the current study further indicate a persis-
tence of the parent drugs in s.c. AT for the duration of the 
experiment, because quite similar concentrations were 
observed over the entire observation period until the end of 
the experiment (Table 1). These findings are in line with our 
previous study providing data on the TK properties of the 
parent drugs in pig serum (Schaefer et al. 2018a, b). The fact 
that the drug concentrations in serum rapidly reached their 
maximum a few minutes after the beginning of the inhala-
tive administration followed by a steep decrease (see also 
the ratio of the maximum concentration in AT to the cor-
responding concentration in serum; Table 3) was explained 
by a very immediate distribution into deep compartments 
(Schaefer et al. 2018a, b). This explanatory approach was 
further reinforced by the high volumes of distribution cal-
culated based on the data of that TK study (Schaefer et al. 
2018a, b).
Fig. 2  Time- and temperature-dependent postmortem concentration changes of 
a JWH-210, b RCS-4, c THC and d HO-RCS-4.  PMI 1, (4 °C);  PMI 
1, (RT);  PMI 2, (4 °C);  PMI 2, (RT);  PMI 3, (4 °C);  PMI 
3, (RT); in pig subcutaneous (s.c.), perirenal and dorsal adipose tissue (AT) 
following pulmonary administration of a 200  μg/kg body weight dose each. 
Concentrations are displayed as the median concentration change compared to 
concentrations calculated at PMI 0; RT room temperature
Table 3  Data on basicity  [pka, (ChemIDplus 2020)], lipophilicity 
(logP, according to Schaefer et al. (2017b)), ratio of maximum con-
centration in adipose tissue (Cat) and corresponding concentration 
in serum (Cse) according to Schaefer et al. (2019) and adipose tissue 
storage index (ASI) calculated as a quotient of Cat and relative admin-
istered dose of JWH-210, RCS-4, and THC; n.a. not available
Cannabinoid pka logP Cat/Cse ASI
JWH-210 n.a. 7.5 1.7 0.10
RCS-4 n.a. 5.6 5.7 0.12
THC 10.6 6.7 1.0 0.11
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In line with our findings, a rapid uptake of THC into AT 
has already been discussed, e.g., by Rawitch et al. (1979). 
These authors assessed maximum concentrations in mouse 
gonadal AT a few minutes after intraperitoneal injection. 
The concentrations also dropped to a plateau level that was 
maintained for at least 6 h.
Regarding SCs, no data on their time-course of uptake 
into AT are available. However, in some TK studies on 
blood concentration–time profiles a distribution into AT and 
a sequestration in this tissue was at least discussed hypo-
thetically. One study was performed with the two so-called 
‘new generation’ SC CUMYL-PICA and 5F-CUMYL-PICA 
using rats (Kevin et al. 2017). The authors showed a similar 
time-course of distribution in plasma than we found in our 
TK study (Schaefer et al. 2018a, b). To explain the slow 
clearance from plasma, they discussed a possible persistence 
in and redistribution from AT. As a consequence, SC could 
be supposed to passively and slowly diffuse into blood again 
during abstinence or food deprivation (Kevin et al. 2017). 
This hypothesis was also supported by Franz et al. (2020) 
assessing an extraordinary long detection window of a SC 
metabolite in human urine. The aforementioned phenomena 
have already been described for THC (Gunasekaran et al. 
2009; Johansson et al. 1989), leading to the conclusion that 
a storage in AT might alter the TK of a drug being an impor-
tant issue with regard to abstinence control programs. As a 
consequence, TD, that is to say, the psychotropic drug effects 
might be influenced.
When determining concentrations in AT as a function of 
time, possible mechanisms of uptake into adipocytes have to 
be discussed. The most important issue might be the lipophi-
licity of a drug, expressed as a high octanol/water coefficient 
(logP). Thiopental with a logP value of 2.8 is said to be a 
prototype of a ‘fat-seeker’ accumulating with high affinity in 
AT (Mühlebach et al. 1985). According to an in vitro study 
by Betschart et al. (1988), evidence is provided that those 
drugs with a logP value below 2 are not supposed to be 
stored in AT. However, some highly lipophilic drugs such 
as methadone, imipramine, amitriptyline and chlorproma-
zine are not significantly taken up by adipocytes in vivo 
(Betschart et al. 1988; Mühlebach et al. 1985), implicating 
that distribution into AT is not simply a matter of lipid solu-
bility. In fact, Mühlebach et al. (1985) demonstrated that the 
rates of invasion into AT considerably decrease with increas-
ing lipophilicity. Particularly, the chemical structure of basic 
lipophilic drugs seems to play an important role concerning 
the extent of AT storage (Moor et al. 1992). In this con-
text, high affinity binding to rapidly perfused organs due 
to lysosomal trapping (also called lysosomotropism) might 
be the underlying mechanism (Macintyre and Cutler 1988). 
Xie et al. (1991) investigated the AT uptake and storage of 
benzodiazepines with different basic properties  (pka) and 
drew the conclusion that drugs with  pka < 7 are likely to be 
stored in AT and those with  pka > 7 show no considerable 
persistence.
For the drugs analyzed in the present study, no data are 
available concerning  pka values of JWH-210 and RCS-4. 
Those substances contain a tertiary amine located in an 
indole core resulting in only weak basic properties. THC 
has a  pka of about 10 [Table 3; (ChemIDplus 2020)] sug-
gesting only low storage affinity. However, as a substance 
with a phenol moiety, it has weak acidic properties because 
of the mesomerism-stabilized anion of the phenolate. As for 
the lipophilic properties of the cannabinoids, logP values 
(see Table 3) are higher than the logP values of the studied 
benzodiazepines (Xie et al. 1991) and even higher than the 
logP of the ‘fat-seeker’ prototype thiopental (Mühlebach 
et al. 1985). However, the AT storage indices are consist-
ently < 1 (Table 3) implicating a low distribution into AT 
as compared to other tissues. Unfortunately, specimens of 
the other tissues and organs were only sampled at the end 
of the experiment. Thus, the AM kinetics in AT could not 
be compared with concentration–time profiles in other tis-
sues. However, the time-course of concentrations in s.c. AT 
indicate a stable retention in this tissue.
The analyses of metabolites in AM AT specimens indi-
cated that only HO-RCS-4 was found. Although being more 
lipophilic than HO-RCS-4, the main metabolites of the other 
two cannabinoids might not be distributed into AT, because 
they are not eliminated in their free form, but as highly 
hydrophilic glucuronides (Schaefer et al. 2018a, b). Since 
no enzymatic cleavage was performed in this study, only the 
free metabolites, but not the glucuronides could be detected.
PM concentrations and time‑ 
and temperature‑dependent concentration changes
At the time of death (8 h after administration), the concen-
trations of the parent drugs in s.c. AT had not changed con-
siderably as compared to the maximum AM AT concentra-
tions. The concentrations in perirenal AT were resembled 
to those measured in s.c. AT except for JWH-210 exhibit-
ing the highest concentrations in this region (Table 2). This 
might be explained by the fact that JWH-210 is supposed to 
accumulate in kidneys (Schaefer et al. 2017b, 2019). Thus, a 
diffusion into the surrounding perirenal AT seems possible. 
In accordance with previously published data (Schaefer et al. 
2017b), lowest drug concentrations were observed in dorsal 
AT. This distribution might be explained by the thicker tex-
ture and a minor supply with blood vessels (Schaefer et al. 
2017b).
Comparing the concentrations in AT at the time of death 
with those in the remaining tissues and organs (Schaefer 
et al. 2019), higher mean concentrations of JWH-210 were 
found in lung (33 ± 19 ng/g) and kidney (25 ± 41 ng/g) 
(Schaefer et al. 2019). As a consequence, besides AT, an 
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additional sequestration of JWH-210 seems to occur into 
lung and kidney. Concerning RCS-4, the concentrations in 
the other tissues were lower as compared to those in AT 
except for lung. In this organ, even slightly higher concentra-
tions (20 ± 19 ng/g) were determined (Schaefer et al. 2019), 
indicating a comparable persistence of RCS-4 in these tis-
sues. As for THC, concentrations were comparably high in 
liver (26 ± 20 ng/g) and bile fluid (25 ± 47 ng/g) and much 
higher in duodenum content (84 ± 66 ng/g) (Schaefer et al. 
2019). However, this discrepancy can be explained by the 
fact that the sample preparation in the former study included 
an enzymatic cleavage. Thus, the total amount of THC and 
THC-glucuronide was detected, leading to higher concentra-
tions in duodenum content due to enterohepatic circulation.
In addition, PM concentrations of the drugs exhibited rel-
evant PM changes in these organs over an observation period 
of 72 h (Schaefer et al. 2020). On the contrary, only minor 
PM concentration changes (p > 0.05) of the parent drugs 
were encountered throughout the tested AT specimens, 
irrespective of storage time and temperature (Fig. 2a–c, 
Table 2). The minor concentration changes (about 100%) 
found might be attributable to interindividual and analyti-
cal variations. At least, the slight continuous concentration 
increase of RCS-4 in perirenal AT might be a result of PMR 
from the kidneys. The concentration increase of RCS-4 in 
s.c. AT at PMI 1 (4 °C) might be explained by one pig exhib-
iting great intra-individual variability (see Fig. 2b, Table 2). 
These findings indicate a PM stability of the drugs in AT 
with concentrations not considerably being altered by so-
called PMR phenomena. A resistance of AT towards PMR 
has already been discussed elsewhere (Levisky et al. 2001). 
As far as THC is concerned, Brunet et al. (2010), studying 
the time-dependent PMR of THC in pigs following intra-
venous administration of a 200 µg/kg BW dose, provided 
similar data.
Regarding SC, scientific data on their distribution are 
very sparse. However, many fatal case reports have been 
published (Castaneto et al. 2015; Kraemer et al. 2019; Meyer 
2016). As far as analytical data on AT distribution were pro-
vided, comparable or even much higher SC concentrations 
were reported (Castaneto et al. 2015; Kraemer et al. 2019). 
The interpretation of the differences is difficult yet, because 
time and dose of intake or the PMI as well as consump-
tion habits were unknown. In those studies with comparable 
SC AT concentrations, a similar distribution pattern in the 
remaining organs and tissues was observed as in our study 
(Schaefer et al. 2019).
With respect to HO-RCS-4, concentrations in AT after 8 h 
were lower as compared to those detected in the remaining 
tissues (Schaefer et al. 2019), suggesting a minor AT stor-
age potential.
The concentrations of the metabolite in s.c. and dorsal AT 
seemed to be stable at least over 72 h (Fig. 2d). However, in 
perirenal AT a significant time-dependent increase (p < 0.05) 
was observed during storage at RT (Fig. 2d). This phenom-
enon might again be explained by the vicinity of perirenal 
AT to the kidneys.
Conclusion
Antemortem distribution patterns and PM time- and tem-
perature-dependent concentration changes of the two SC 
JWH-210 and RCS-4 as well as THC following pulmonary 
administration were investigated in pigs. The results suggest 
a rapid distribution of the cannabinoids into s.c. AT and a 
sequestration in this tissue within the observation period of 
72 h allowing for redistribution. This issue has to be consid-
ered in the context of abstinence control analyses, especially 
with regard to users with chronic consumption habits. In 
addition, the findings indicate that AT might be resistant to 
PMR of parent compounds and, therefore, viable as alterna-
tive matrix in PM toxicology. As for metabolites, the less 
lipophilic HO-RCS-4 was the only metabolite detected in 
AT specimens, probably as the other analyzed metabolites 
are only distributed and eliminated as glucuronides. Last but 
not least, significant PM increases of metabolite concentra-
tions might be considered in perirenal AT due to immediate 
vicinity to the kidneys.
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